Why Size and Shape do matter.
In April 2020, Yokogawa announced the acquisition of the US company Fluid Imaging Technologies Inc (YFT). This article will briefly…
In April 2020, Yokogawa announced the acquisition of the US company Fluid Imaging Technologies Inc (YFT). This article will briefly…
Ulrich Pichler is the director of Yokogawa’s Life Innovation Business (LIB) in Europe. In this blog, he explains the meaning…
Life Science – How Yokogawa contributes to Well-Being Read More »
The research team of Prof. Prisca Liberali at the Friedrich Miescher Institute for Biomedical Research (FMI) in Basel explored the…
At the end of 2019, the Yokogawa Life Innovation Business (LIB) reported on recent market strategies, product developments, and plans.…
Further shaping the Life Innovation Business (LIB) Read More »
How do you develop new drugs? Here, Andreas Schamber describes the long path from research to the available drug.
Webinar: Professor Dr. Rafael Carazo Salas of the University of Bristol’s School of Cellular and Molecular Medicine will describe multicolor,…
High-Content Imaging on Human Pluripotent Stem Cell Research Read More »
Read our interview with Prisca Liberali, Junior Group Leader at Friedrich Miescher Institute for Biomedical Research in Basel (Switzerland). At…
Together with experts at InSphero and Yokogawa, we are hosting a webinar on January 14, 2021. In this webinar, we share our experience…
Yokogawa decided to support the world’s fight against COVID-19, scientifically cooperating with research facilities actively involved in COVID-19 research. In…
Yokogawa supports COVID-19 research at the Charité in Berlin Read More »